Advisory Council on the Misuse of Drugs (2002) The Classification of Cannabis under the Misuse of Drugs Act 1971. London: Home Office.
Advisory Council on the Misuse of Drugs (2005) Further Consideration of the Classification of Cannabis under the Misuse of Drugs Act 1971. London: Home Office.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn). Washington: American Psychiatric Association.
Arendt, M., Rosenberg, R., Foldager, L.
et al (2005) Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510–515.
Arseneault, L., Cannon, M., Witton, J.
et al (2004) Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry, 184, 110–117.
Baker, A., Bucci, S., Lewin, T. J.
et al (2006) Cognitive–behavioural therapy for substance use disorders in people with psychotic disorders. British Journal of Psychiatry, 188, 439–448.
Budney, A. J., Higgins, S. T., Radanovich, K. J.
et al (2000) Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology, 68, 1051–1061.
Caspi, A., Moffitt, T. E., Cannon, M.
et al (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry, 57, 1117–1127.
Chivite-Matthews, N., Richardson, A., O'Shea, J.
et al (2005) Drug Misuse Declared: Findings from the 2003/04 British Crime Survey. London: Home Office.
Copeland, J., Swift, W., Roffman, R.
et al (2001) A randomised controlled trial of brief cognitive–behavioural interventions for cannabis use disorder. Journal of Substance Abuse Treatment, 21, 55–64.
Coulthard, M., Farrell, M., Singleton, N.
et al (2002) Tobacco, Alcohol and Drug Use and Mental Health. London: TSO (The Stationery Office).
Dennis, M., Godley, S., Diamond, G.
et al (2004) The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. Journal of Substance Abuse Treatment, 27, 197–213.
D'Souza, C., Cho, H. S., Perry, E.
et al (2004) A cannabinoid model psychosis, dopamine-cannabinoid interactions and implications for schizophrenia. In Marijuana and Madness (eds Castle, D. J. & Murray, R.) pp. 142–165. Cambridge: Cambridge University Press.
Green, A. (2005) Schizophrenia and comorbid substance use disorder: effects of antipsychotics. Journal of Clinical Psychiatry, 66 (suppl. 6), 21–26.
Green, B., Kavanagh, D. J. & Young, R. M. (2004) Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review, 23, 445–453.
Haddock, G., Barrowclough, C., Tarrier, N.
et al (2003) Cognitive–behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. British Journal of Psychiatry, 183, 418–426.
Hser, Y., Grella, C. E., Hubbard, R. L.
et al (2001) An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry, 58, 689–695.
Huestis, M. A., Gorelick, D. A., Heishman, S. J.
et al (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Archives of General Psychiatry, 58, 322–328.
Iversen, L. (2005) Long-term effects of exposure to cannabis. Current Opinion in Pharmacology, 5, 69–72.
Kendell, R. (2003) Cannabis condemned: the proscription of Indian Hemp. Addiction, 98, 143–151.
Levin, F. R., McDowell, D., Evans, S. M.
et al (2004) Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. American Journal of Addiction, 13, 21–32.
Marijuana Treatment Project Research Group (2004) Brief treatments for cannabis dependence: findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology, 72, 455–466.
Marlatt, G. A. & Gordon, J. R. (1985) Relapse Prevention: A Self-Control Strategy for the Maintenance of Behaviour Change. New York: Guilford Press.
Martin, G., Copeland, J. & Swift, W. (2005) The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users. Journal of Substance Abuse Treatment, 29, 207–213.
McCambridge, J. & Strang, J. (2004) The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomised trial. Addiction, 99, 39–52.
McRae, A. L., Budney, A. J. & Brady, K. T. (2003) Treatment of marijuana dependence: a review of the literature. Journal of Substance Abuse Treatment, 24, 369–376.
Miller, W. R. & Rollnick, S. (2002) Motivational Interviewing: Preparing People for Change. New York: Guilford Press.
Stephens, R. S., Roffman, R. A. & Simpson, E. E. (1994) Treatment of adult marijuana dependence: a test of the relapse prevention model. Journal of Consulting and Clinical Psychology, 62, 92–99.
Stephens, R. S., Roffman, R. A. & Curtin, L. (2000) Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68, 898–908.
Treffert, D. (1978) Marijuana use in schizophrenia: a clear hazard. American Journal of Psychiatry, 135, 1213–1215.
Turner, W. M. & Tsuang, M.T. (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophrenia Bulletin, 16, 1990.
World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.
Wright, F. D., Beck, A. T., Newman, C. F.
et al (1993) Cognitive Therapy of Substance Abuse. New York: Guilford Press.